| abstract |
The instant invention provides a method of treating a cancer selected from the group consisting of non-small cell lung cancer, breast cancer, colorectal cancer, soft tissue or bone sarcomas and endometrial cancer with an mTOR inhibitor and an anti-IGF-1R antibody, wherein the mTOR inhibitor is ridaforolimus, everolimus, temsirolimus or a combination thereof. |